Symbol="GDTC"
AssetType="Common Stock"
Name="CytoMed Therapeutics Limited Ordinary Shares"
Description="CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company is headquartered in Singapore."
CIK="1873093"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1 COMMONWEALTH LANE, #08-22, 1 COMMONWEALTH LANE, SG"
FiscalYearEnd="December"
LatestQuarter="None"
MarketCapitalization="None"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="None"
DividendPerShare="None"
DividendYield="None"
EPS="None"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0"
ReturnOnEquityTTM="0"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="0"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="5.75"
num_52WeekLow="2.36"
num_50DayMovingAverage="0"
num_200DayMovingAverage="0"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="GDTC"
open="4.13"
high="4.40"
low="4.10"
price="4.30"
volume="97449.00"
latest_trading_day="2023-07-17"
previous_close="4.34"
change="-0.04"
change_percent="-0.9217%"
aroon_positive_momentum_days="4"
aroon_negative_momentum_days="0"
trend_strength="nan"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="4"
Volume_recent_avg="540065"
Change_recent_avg="-0.07"
Delta_recent_avg="0.45"
Variance_recent_avg="0.22"
Change_ratio_recent_avg="-1.75"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="4"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="156"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_negative_thumbnail_id_2="508"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="972"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0134.jpeg"
image_positive_thumbnail_id_2="968"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
